Skip Nav Destination
Issues
1 August 2019
-
Cover Image
Cover Image
The cover shows the deep surface of a head and neck tumor specimen. At 2 days prior to surgery, the patient underwent systemic infusion of panitumumab-IRDye800 bioconjugate that will display fluorescence when excited in the near-infrared range. The deep surface of the specimen is positioned facing the camera, so that the tumor regions that are closest to the surface display the highest fluorescence intensities. The highest region of fluorescence is referred to as the “sentinel margin.” For details, see the article by van Keulen and colleagues on page 4656 of the issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Clinical Trial Brief Report
Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Maud Toulmonde; Jean-Yves Blay; Olivier Bouche; Olivier Mir; Nicolas Penel; Nicolas Isambert; Florence Duffaud; Emmanuelle Bompas; Thomas Esnaud; Romain Boidot; Damien Geneste; François Ghiringhelli; Carlo Lucchesi; Carine A. Bellera; François Le Loarer; Antoine Italiano
Clinical Trials: Targeted Therapy
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms
Estrella Carrillo-Cruz; José R. García-Lozano; Francisco J. Márquez-Malaver; Fermín M. Sánchez-Guijo; Isabel Montero Cuadrado; Christelle Ferra i Coll; David Valcárcel; Oriana López-Godino; Marian Cuesta; Rocío Parody; Lucía López-Corral; Miguel Alcoceba; Teresa Caballero-Velázquez; Alfonso Rodríguez-Gil; José A. Bejarano-García; Teresa Lopes Ramos; José A. Pérez-Simón
Author Choice
Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer
Susan Slovin; Syed Hussain; Fred Saad; Jorge Garcia; Joel Picus; Roberta Ferraldeschi; Mateus Crespo; Penelope Flohr; Ruth Riisnaes; Chihche Lin; Harold Keer; Aram Oganesian; Paul Workman; Johann de Bono
Clinical Trials: Immunotherapy
Author Choice
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Magdalena Klanova; Mikkel Z. Oestergaard; Marek Trněný; Wolfgang Hiddemann; Robert Marcus; Laurie H. Sehn; Umberto Vitolo; Alexandra Bazeos; Valentin Goede; Harald Zeuner; Andrea Knapp; Deniz Sahin; Nathalie Spielewoy; Christopher R. Bolen; Andres Cardona; Christian Klein; Jeffrey M. Venstrom; Tina Nielsen; Günter Fingerle-Rowson
Precision Medicine and Imaging
The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative Chemotherapy
Adrienne G. Waks; Daniel G. Stover; Jennifer L. Guerriero; Deborah Dillon; William T. Barry; Evisa Gjini; Christina Hartl; Wesley Lo; Jennifer Savoie; Jane Brock; Robert Wesolowski; Zaibo Li; Adrienne Damicis; Anne V. Philips; Yun Wu; Fei Yang; Amy Sullivan; Patrick Danaher; Heather Ann Brauer; Wafa Osmani; Mikel Lipschitz; Katherine A. Hoadley; Michael Goldberg; Charles M. Perou; Scott Rodig; Eric P. Winer; Ian E. Krop; Elizabeth A. Mittendorf; Sara M. Tolaney
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar; Miguel F. Sanmamed; Jun Wang; Brian S. Henick; Jungmin Choi; Ti Badri; Weilai Dong; Nikita Mani; Maria Toki; Luis D. Mejías; Maria D. Lozano; Jose Luis Perez-Gracia; Vamsidhar Velcheti; Matthew D. Hellmann; Justin F. Gainor; Kristen McEachern; David Jenkins; Konstantinos Syrigos; Katerina Politi; Scott Gettinger; David L. Rimm; Roy S. Herbst; Ignacio Melero; Lieping Chen; Kurt A. Schalper
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma
Martin R. Jones; Laura M. Williamson; James T. Topham; Michael K.C. Lee; Angela Goytain; Julie Ho; Robert E. Denroche; GunHo Jang; Erin Pleasance; Yaoquing Shen; Joanna M. Karasinska; John P. McGhie; Sharlene Gill; Howard J. Lim; Malcolm J. Moore; Hui-li Wong; Tony Ng; Stephen Yip; Wei Zhang; Sara Sadeghi; Carolyn Reisle; Andrew J. Mungall; Karen L. Mungall; Richard A. Moore; Yussanne Ma; Jennifer J. Knox; Steven Gallinger; Janessa Laskin; Marco A. Marra; David F. Schaeffer; Steven J.M. Jones; Daniel J. Renouf
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Bhishamjit S. Chera; Sunil Kumar; Brian T. Beaty; David Marron; Stuart Jefferys; Rebecca Green; Emily C. Goldman; Robert Amdur; Nathan Sheets; Roi Dagan; D. Neil Hayes; Jared Weiss; Juneko E. Grilley-Olson; Adam Zanation; Trevor Hackman; Jeffrey M. Blumberg; Samip Patel; Mark Weissler; Xianming M. Tan; Joel S. Parker; William Mendenhall; Gaorav P. Gupta
Author Choice
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
Natasha B. Leighl; Ray D. Page; Victoria M. Raymond; Davey B. Daniel; Stephen G. Divers; Karen L. Reckamp; Miguel A. Villalona-Calero; Daniel Dix; Justin I. Odegaard; Richard B. Lanman; Vassiliki A. Papadimitrakopoulou
Translational Cancer Mechanisms and Therapy
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
Ryma Benayed; Michael Offin; Kerry Mullaney; Purvil Sukhadia; Kelly Rios; Patrice Desmeules; Ryan Ptashkin; Helen Won; Jason Chang; Darragh Halpenny; Alison M. Schram; Charles M. Rudin; David M. Hyman; Maria E. Arcila; Michael F. Berger; Ahmet Zehir; Mark G. Kris; Alexander Drilon; Marc Ladanyi
Author Choice
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
Urs B. Hagemann; Christine Ellingsen; Joachim Schuhmacher; Alexander Kristian; Anne Mobergslien; Véronique Cruciani; Katrine Wickstroem; Christoph A. Schatz; Christoph Kneip; Sven Golfier; Roger Smeets; Steinar Uran; Hartwig Hennekes; Jenny Karlsson; Roger M. Bjerke; Olav B. Ryan; Dominik Mumberg; Karl Ziegelbauer; Alan S. Cuthbertson
Author Choice
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
Changhua Ji; Marc D. Roy; Jonathan Golas; Allison Vitsky; Sripad Ram; Steven W. Kumpf; Matthew Martin; Frank Barletta; William A. Meier; Andrea T. Hooper; Puja Sapra; Nasir K. Khan; Martin Finkelstein; Magali Guffroy; Bernard S. Buetow
Inhibiting BRAF Oncogene–Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair
Ryan Robb; Linlin Yang; Changxian Shen; Adam R. Wolfe; Amy Webb; Xiaoli Zhang; Marall Vedaie; Motoyasu Saji; Sissy Jhiang; Matthew D. Ringel; Terence M. Williams
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
Hong-Wei Wu; Michael A. Sheard; Jemily Malvar; G. Esteban Fernandez; Yves A. DeClerck; Laurence Blavier; Hiroyuki Shimada; Charles P. Theuer; Richard Sposto; Robert C. Seeger
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou; Catherine Lozza; Alexandre Pichard; Julie Constanzo; Jihad Karam; Pierre Le Fur; Emmanuel Deshayes; Vincent Boudousq; Salomé Paillas; Muriel Busson; Marion Le Blay; Marta Jarlier; Sara Marcatili; Manuel Bardiès; Frank Bruchertseifer; Alfred Morgenstern; Julien Torgue; Isabelle Navarro-Teulon; Jean-Pierre Pouget
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
Tokiyoshi Tanegashima; Yosuke Togashi; Koichi Azuma; Akihiko Kawahara; Ko Ideguchi; Daisuke Sugiyama; Fumio Kinoshita; Jun Akiba; Eiji Kashiwagi; Ario Takeuchi; Takuma Irie; Katsunori Tatsugami; Tomoaki Hoshino; Masatoshi Eto; Hiroyoshi Nishikawa
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova; Jana Rakova; Michal Hensler; Lenka Kasikova; Lucie Belicova; Kamila Hladikova; Iva Truxova; Petr Skapa; Jan Laco; Ladislav Pecen; Ivan Praznovec; Michael J. Halaska; Tomas Brtnicky; Roman Kodet; Anna Fialova; Josephine Pineau; Alain Gey; Eric Tartour; Ales Ryska; Lorenzo Galluzzi; Radek Spisek
Author Choice
Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness
Ángela Molina-Crespo; Ana Cadete; David Sarrio; Manuel Gámez-Chiachio; Lidia Martinez; Kinlin Chao; Ana Olivera; Andrea Gonella; Eva Díaz; José Palacios; Pradeep K. Dhal; Magnus Besev; Macarena Rodríguez-Serrano; María Laura García Bermejo; Juan Carlos Triviño; Amparo Cano; Marcos García-Fuentes; Osnat Herzberg; Dolores Torres; Maria José Alonso; Gema Moreno-Bueno
Corrections
Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Maud Toulmonde; Jean-Yves Blay; Olivier Bouche; Olivier Mir; Nicolas Penel; Nicolas Isambert; Florence Duffaud; Emmanuelle Bompas; Thomas Esnaud; Romain Boidot; Damien Geneste; François Ghiringhelli; Carlo Lucchesi; Carine A. Bellera; François Le Loarer; Antoine Italiano
Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström Macroglobulinemia
Aldo M. Roccaro; Xavier Leleu; Antonio Sacco; Anne-Sophie Moreau; Evdoxia Hatjiharissi; Xiaoying Jia; Lian Xu; Bryan Ciccarelli; Christopher J. Patterson; Hai T. Ngo; Domenico Russo; Angelo Vacca; Franco Dammacco; Kenneth C. Anderson; Irene M. Ghobrial; Steven P. Treon
Editor’s Notes
Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma
Seung-Hyun Oh; Woo-Young Kim; Jai-Hyun Kim; Maher N. Younes; Adel K. El-Naggar; Jeffrey N. Myers; Merril Kies; Pinchas Cohen; Fadlo Khuri; Waun K. Hong; Ho-Young Lee
Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Bradley A. Schiff; Andrea B. McMurphy; Samar A. Jasser; Maher N. Younes; Dao Doan; Orhan G. Yigitbasi; Seungwon Kim; Ge Zhou; Mahitosh Mandal; Benjamin N. Bekele; F. Christopher Holsinger; Steven I. Sherman; Sai-Ching Yeung; Adel K. El-Naggar; Jeffrey N. Myers
Advertisement